BioLife Solutions (BLFS) News Today $26.14 -0.31 (-1.17%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period BioLife Solutions, Inc. (NASDAQ:BLFS) Receives $29.43 Consensus PT from AnalystsJanuary 21 at 1:07 AM | americanbankingnews.comShort Interest in BioLife Solutions, Inc. (NASDAQ:BLFS) Rises By 5.8%BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 3,310,000 shares, a growth of 5.8% from the December 15th total of 3,130,000 shares. Based on an average trading volume of 379,000 shares, the short-interest ratio is presently 8.7 days.January 19 at 12:31 PM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of "Buy" by BrokeragesShares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned an average recommendation of "Buy" from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The averageJanuary 18 at 2:46 AM | marketbeat.comCraig-Hallum Sticks to Their Buy Rating for BioLife Solutions (BLFS)January 15, 2025 | markets.businessinsider.comWhat is Northland Capmk's Forecast for BLFS Q4 Earnings?January 14, 2025 | americanbankingnews.comBioLife Solutions sees Q4 revenue $22.7M, consensus $21.55MJanuary 13, 2025 | markets.businessinsider.comBioLife Solutions, Inc.: BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing OperationsJanuary 13, 2025 | finanznachrichten.deBioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing OperationsJanuary 13, 2025 | prnewswire.comQ4 EPS Estimate for BioLife Solutions Decreased by AnalystBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at Northland Capmk lowered their Q4 2024 earnings estimates for shares of BioLife Solutions in a research report issued to clients and investors on Wednesday, January 8th. Northland Capmk analyst C. Byrnes now expects that thJanuary 13, 2025 | marketbeat.comResearch Analysts Set Expectations for BLFS Q4 EarningsJanuary 12, 2025 | americanbankingnews.comCraig-Hallum Reaffirms Their Buy Rating on BioLife Solutions (BLFS)January 10, 2025 | markets.businessinsider.comNorthland Capmk Weighs in on BLFS Q4 EarningsBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Equities researchers at Northland Capmk issued their Q4 2025 earnings per share (EPS) estimates for BioLife Solutions in a research note issued on Wednesday, January 8th. Northland Capmk analyst C. Byrnes anticipates that the medical equipmentJanuary 10, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells $10,916.08 in StockJanuary 9, 2025 | insidertrades.comNorthland Securities Remains a Buy on BioLife Solutions (BLFS)January 9, 2025 | markets.businessinsider.comBioLife Solutions price target raised to $31 from $28 at NorthlandJanuary 9, 2025 | markets.businessinsider.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 404 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 404 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $27.02, for a total value of $10,916.08. Following the transaction, the executive vice president now directly owns 262,715 shares of the company's stock, valued at approximately $7,098,559.30. The trade was a 0.15 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.January 8, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $26,668.74 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 987 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $27.02, for a total value of $26,668.74. Following the completion of the sale, the chief financial officer now directly owns 121,779 shares in the company, valued at approximately $3,290,468.58. The trade was a 0.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.January 8, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CEO Greef Roderick De Sells 46,896 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CEO Greef Roderick De sold 46,896 shares of the firm's stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $23.43, for a total value of $1,098,773.28. Following the completion of the sale, the chief executive officer now owns 414,958 shares in the company, valued at approximately $9,722,465.94. This represents a 10.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 8, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Price Target Raised to $31.00 at Northland SecuritiesNorthland Securities lifted their target price on BioLife Solutions from $28.00 to $31.00 and gave the company an "outperform" rating in a research note on Wednesday.January 8, 2025 | marketbeat.comKeyBanc Sticks to Its Buy Rating for BioLife Solutions (BLFS)January 7, 2025 | markets.businessinsider.comBioLife Solutions (BLFS) Receives a Buy from TD CowenJanuary 7, 2025 | markets.businessinsider.comBioLife Solutions: Optimizing Its Business ModelJanuary 2, 2025 | seekingalpha.comJane Street Group LLC Trims Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Jane Street Group LLC lessened its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 47.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 46,654 shares of the medical equipment provider's stock after sellingDecember 30, 2024 | marketbeat.comTD Cowen Remains a Buy on BioLife Solutions (BLFS)December 24, 2024 | markets.businessinsider.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Recommendation of "Buy" by BrokeragesShares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1 year price oDecember 24, 2024 | marketbeat.comState Street Corp Acquires 95,788 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)State Street Corp lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 7.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,412,316 shares of the medical equipment prDecember 21, 2024 | marketbeat.comBenchmark Co. Sticks to Their Buy Rating for BioLife Solutions (BLFS)December 20, 2024 | markets.businessinsider.comBioLife Solutions (NASDAQ:BLFS) Shares Up 4.2% - What's Next?BioLife Solutions (NASDAQ:BLFS) Shares Up 4.2% - Here's WhyDecember 20, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 7,604 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 7,604 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $27.33, for a total value of $207,817.32. Following the completion of the sale, the executive vice president now directly owns 276,315 shares in the company, valued at approximately $7,551,688.95. This represents a 2.68 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.December 19, 2024 | marketbeat.comBioLife Solutions' (BLFS) "Buy" Rating Reiterated at BenchmarkBenchmark restated a "buy" rating and issued a $30.00 price target on shares of BioLife Solutions in a research report on Thursday.December 19, 2024 | marketbeat.comBioLife Solutions Appoints Tony J. Hunt to its Board of DirectorsDecember 16, 2024 | prnewswire.comBioLife Solutions price target raised to $33 from $30 at KeyBancDecember 13, 2024 | markets.businessinsider.comBioLife Solutions (BLFS) Receives a Buy from KeyBancDecember 13, 2024 | markets.businessinsider.comKeyCorp Forecasts Strong Price Appreciation for BioLife Solutions (NASDAQ:BLFS) StockKeyCorp boosted their price objective on shares of BioLife Solutions from $30.00 to $33.00 and gave the company an "overweight" rating in a research note on Friday.December 13, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Meros Investment Management LPMeros Investment Management LP cut its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 56.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 173,910 shares of the medical equipment provider'sDecember 11, 2024 | marketbeat.comPolar Asset Management Partners Inc. Sells 63,000 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)Polar Asset Management Partners Inc. trimmed its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 85.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,638 shares of the medical equipment provider's stDecember 7, 2024 | marketbeat.comEstimating The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)December 6, 2024 | finance.yahoo.comRockefeller Capital Management L.P. Raises Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Rockefeller Capital Management L.P. grew its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 81.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 585,497 shares of the medical equipment provider's stock after buying an additional 262,504 sharesDecember 3, 2024 | marketbeat.comD.A. Davidson & CO. Makes New $1.02 Million Investment in BioLife Solutions, Inc. (NASDAQ:BLFS)D.A. Davidson & CO. purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 40,660 shares of the medical equipment proDecember 2, 2024 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 523 Shares of StockNovember 30, 2024 | insidertrades.comBioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest UpdateBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 2,680,000 shares, a decrease of 23.4% from the October 31st total of 3,500,000 shares. Based on an average trading volume of 384,000 shares, the short-interest ratio is currently 7.0 days.November 29, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells $14,225.60 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 523 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $27.20, for a total transaction of $14,225.60. Following the completion of the sale, the executive vice president now owns 283,919 shares in the company, valued at approximately $7,722,596.80. This trade represents a 0.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.November 29, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $15,803.20 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 581 shares of BioLife Solutions stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $27.20, for a total transaction of $15,803.20. Following the completion of the sale, the chief financial officer now owns 122,766 shares in the company, valued at approximately $3,339,235.20. This represents a 0.47 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.November 29, 2024 | marketbeat.comIsthmus Partners LLC Has $3.31 Million Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Isthmus Partners LLC lowered its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 20.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,047 shares of the medical equipment provNovember 29, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of "Buy" by AnalystsShares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objecNovember 29, 2024 | marketbeat.comVictory Capital Management Inc. Sells 42,851 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)Victory Capital Management Inc. reduced its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 50.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,934 shares of the medical equipment provideNovember 28, 2024 | marketbeat.comResearch Analysts Issue Forecasts for BLFS Q1 EarningsBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for BioLife Solutions in a report released on Monday, November 18th. HC Wainwright analyst Y. Chen expects that the medical equipment provider will postNovember 20, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 17,604 SharesNovember 20, 2024 | insidertrades.comAnalyst Expectations For BioLife Solns's FutureNovember 18, 2024 | benzinga.comBioLife Solutions price target lowered to $27 from $29 at H.C. WainwrightNovember 18, 2024 | markets.businessinsider.com Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address BLFS Media Mentions By Week BLFS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLFS News Sentiment▼0.180.48▲Average Medical News Sentiment BLFS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLFS Articles This Week▼64▲BLFS Articles Average Week Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inari Medical News Today PROCEPT BioRobotics News Today Envista News Today iRhythm Technologies News Today NovoCure News Today LivaNova News Today Enovis News Today Warby Parker News Today Tandem Diabetes Care News Today LeMaitre Vascular News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLFS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.